News

Our news cover the latest topics from the past 30 days, as retrieved from Chinese-language press releases and other information sources.

For older news topics, please use the archive button.

Please use the search module to retrieve information on institutes, researchers and research topics

 

Shandong Province starts hot water supply for heating by a nuclear power plant in Yantai

The Haiyang Nuclear Power Station in Yantai has initiated hot water supply to households, substituting hot water generated in a coal-based thermal power generator. It will initially provide heating for an area of 700,000 m2, covering the dormitories of its employees and about 30 other neighborhoods. As a heat source, steam from the loop of reactor 2 is used. Heat exchange is repeated at a heat exchange station of the heating company outside the power plant, and finally the heat is delivered to each household through the municipal heating pipe network.

Xinhuanet news release, December 11, 2019

Haiyang Nuclear Power Plant

2016 China’s R&D expenditure was 2.1 % of GDP

From the total expenditure of 1567.7 billion Yuan (+ 10.6 % compared to 2015), 5.2 was spent for basic research, 10.3 % for applied research, and 84.5 % for investments and infrastructure. Industry supplied 77.5 %, the central government 14.4 %, and local units 6.8 %....

read more

China’s stem-cell related industry shows healthy growth

According to a survey by Sina Publisher, China at present has over 100 different stem cell industry-related enterprises. Since 2011, when the State Health Commission and the Food and Drug Administration jointly stopped stem cell clinical research and application...

read more

China launches unhackable Beijing-Shanghai quantum link

The system is based on Micius, the world's first quantum communication satellite, which was launched by China in 2016. In the near future, the backbone of this system will connect Beijing, Shanghai, Jinan (Shandong province) and Hefei (Anhui province). Mr BAI Chunli,...

read more

Merck KGaA opens BioReliance Biodevelopment Center in Shanghai

The center offers competencies and services for bioprocess development, e. g., for the development of cell lines, and upstream and downstream processes. Target customers are SMEs in the Asia-Pacific region which work on clinical studies in an early phase. China Bio...

read more

China’s vaccine industry: 64 kinds, 25 billion Yuan sales

China implemented a child immunization program in 1978 which is steadily expanding. In early 2017, there were 43 approved vaccine companies, accounting for 40% of the global vaccine production enterprises. About 300 companies are involved in vaccine R&D, including...

read more